brl 41992 has been researched along with mk 912 in 2 studies
| Studies (brl 41992) | Trials (brl 41992) | Recent Studies (post-2010) (brl 41992) | Studies (mk 912) | Trials (mk 912) | Recent Studies (post-2010) (mk 912) |
|---|---|---|---|---|---|
| 6 | 0 | 0 | 60 | 3 | 2 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Neubig, RR; Porter, AC; Uhlén, S | 1 |
| Uhlén, S; Wikberg, JE; Wikberg-Matsson, A | 1 |
2 other study(ies) available for brl 41992 and mk 912
| Article | Year |
|---|---|
The novel alpha-2 adrenergic radioligand [3H]-MK912 is alpha-2C selective among human alpha-2A, alpha-2B and alpha-2C adrenoceptors.
Topics: Adrenergic alpha-Antagonists; Animals; Binding, Competitive; CHO Cells; Cricetinae; Dibenzazepines; Humans; Imidazoles; Indoles; Isoindoles; Quinolizines; Radioligand Assay; Receptors, Adrenergic, alpha-2 | 1994 |
Identification of drugs subtype-selective for alpha 2A-, alpha 2B-, and alpha 2C-adrenoceptors in the pig cerebellum and kidney cortex.
Topics: Animals; Binding, Competitive; Cerebellum; Dibenzazepines; Dioxanes; Idazoxan; Imidazoles; Kidney Cortex; Quinolizines; Receptors, Adrenergic, alpha-2; Swine | 1995 |